COVID-19 Impact on Global Recombinant Coagulation Factors Market Size, Status and Forecast 2020-2026

August 2020 | 95 pages | ID: C2C917FB08CAEN
QYResearch

Abstracts

This report focuses on the global Recombinant Coagulation Factors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recombinant Coagulation Factors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Baxter International Inc.
• Bayer AG
• Biogen Idec
• CSL Ltd.
• Grifols International SA
• Kedrion S.P.A.
• Novo Nordisk A/S
• Octapharma AG
• Pfizer Inc.

Market segment by Type, the product can be split into

• Recombinant Factor VIII
• Recombinant Factor IX
• Von Willebrand Factor

Market segment by Application, split into

• Hospitals
• Clinics
• Research Organizations

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Recombinant Coagulation Factors status, future forecast, growth opportunity, key market and key players.
• To present the Recombinant Coagulation Factors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Recombinant Coagulation Factors are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant Coagulation Factors Revenue
1.4 Market Analysis by Type
  1.4.1 Global Recombinant Coagulation Factors Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Recombinant Factor VIII
  1.4.3 Recombinant Factor IX
  1.4.4 Von Willebrand Factor
1.5 Market by Application
  1.5.1 Global Recombinant Coagulation Factors Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Research Organizations
1.6 Coronavirus Disease 2019 (Covid-19): Recombinant Coagulation Factors Industry Impact
  1.6.1 How the Covid-19 is Affecting the Recombinant Coagulation Factors Industry
    1.6.1.1 Recombinant Coagulation Factors Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Recombinant Coagulation Factors Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Recombinant Coagulation Factors Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Recombinant Coagulation Factors Market Perspective (2015-2026)
2.2 Recombinant Coagulation Factors Growth Trends by Regions
  2.2.1 Recombinant Coagulation Factors Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Recombinant Coagulation Factors Historic Market Share by Regions (2015-2020)
  2.2.3 Recombinant Coagulation Factors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Recombinant Coagulation Factors Market Growth Strategy
  2.3.6 Primary Interviews with Key Recombinant Coagulation Factors Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Recombinant Coagulation Factors Players by Market Size
  3.1.1 Global Top Recombinant Coagulation Factors Players by Revenue (2015-2020)
  3.1.2 Global Recombinant Coagulation Factors Revenue Market Share by Players (2015-2020)
  3.1.3 Global Recombinant Coagulation Factors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant Coagulation Factors Market Concentration Ratio
  3.2.1 Global Recombinant Coagulation Factors Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Recombinant Coagulation Factors Revenue in 2019
3.3 Recombinant Coagulation Factors Key Players Head office and Area Served
3.4 Key Players Recombinant Coagulation Factors Product Solution and Service
3.5 Date of Enter into Recombinant Coagulation Factors Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Recombinant Coagulation Factors Historic Market Size by Type (2015-2020)
4.2 Global Recombinant Coagulation Factors Forecasted Market Size by Type (2021-2026)

5 RECOMBINANT COAGULATION FACTORS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Recombinant Coagulation Factors Market Size by Application (2015-2020)
5.2 Global Recombinant Coagulation Factors Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Recombinant Coagulation Factors Market Size (2015-2020)
6.2 Recombinant Coagulation Factors Key Players in North America (2019-2020)
6.3 North America Recombinant Coagulation Factors Market Size by Type (2015-2020)
6.4 North America Recombinant Coagulation Factors Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Recombinant Coagulation Factors Market Size (2015-2020)
7.2 Recombinant Coagulation Factors Key Players in Europe (2019-2020)
7.3 Europe Recombinant Coagulation Factors Market Size by Type (2015-2020)
7.4 Europe Recombinant Coagulation Factors Market Size by Application (2015-2020)

8 CHINA

8.1 China Recombinant Coagulation Factors Market Size (2015-2020)
8.2 Recombinant Coagulation Factors Key Players in China (2019-2020)
8.3 China Recombinant Coagulation Factors Market Size by Type (2015-2020)
8.4 China Recombinant Coagulation Factors Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Recombinant Coagulation Factors Market Size (2015-2020)
9.2 Recombinant Coagulation Factors Key Players in Japan (2019-2020)
9.3 Japan Recombinant Coagulation Factors Market Size by Type (2015-2020)
9.4 Japan Recombinant Coagulation Factors Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Recombinant Coagulation Factors Market Size (2015-2020)
10.2 Recombinant Coagulation Factors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant Coagulation Factors Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant Coagulation Factors Market Size by Application (2015-2020)

11 INDIA

11.1 India Recombinant Coagulation Factors Market Size (2015-2020)
11.2 Recombinant Coagulation Factors Key Players in India (2019-2020)
11.3 India Recombinant Coagulation Factors Market Size by Type (2015-2020)
11.4 India Recombinant Coagulation Factors Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Recombinant Coagulation Factors Market Size (2015-2020)
12.2 Recombinant Coagulation Factors Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant Coagulation Factors Market Size by Type (2015-2020)
12.4 Central & South America Recombinant Coagulation Factors Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Baxter International Inc.
  13.1.1 Baxter International Inc. Company Details
  13.1.2 Baxter International Inc. Business Overview and Its Total Revenue
  13.1.3 Baxter International Inc. Recombinant Coagulation Factors Introduction
  13.1.4 Baxter International Inc. Revenue in Recombinant Coagulation Factors Business (2015-2020))
  13.1.5 Baxter International Inc. Recent Development
13.2 Bayer AG
  13.2.1 Bayer AG Company Details
  13.2.2 Bayer AG Business Overview and Its Total Revenue
  13.2.3 Bayer AG Recombinant Coagulation Factors Introduction
  13.2.4 Bayer AG Revenue in Recombinant Coagulation Factors Business (2015-2020)
  13.2.5 Bayer AG Recent Development
13.3 Biogen Idec
  13.3.1 Biogen Idec Company Details
  13.3.2 Biogen Idec Business Overview and Its Total Revenue
  13.3.3 Biogen Idec Recombinant Coagulation Factors Introduction
  13.3.4 Biogen Idec Revenue in Recombinant Coagulation Factors Business (2015-2020)
  13.3.5 Biogen Idec Recent Development
13.4 CSL Ltd.
  13.4.1 CSL Ltd. Company Details
  13.4.2 CSL Ltd. Business Overview and Its Total Revenue
  13.4.3 CSL Ltd. Recombinant Coagulation Factors Introduction
  13.4.4 CSL Ltd. Revenue in Recombinant Coagulation Factors Business (2015-2020)
  13.4.5 CSL Ltd. Recent Development
13.5 Grifols International SA
  13.5.1 Grifols International SA Company Details
  13.5.2 Grifols International SA Business Overview and Its Total Revenue
  13.5.3 Grifols International SA Recombinant Coagulation Factors Introduction
  13.5.4 Grifols International SA Revenue in Recombinant Coagulation Factors Business (2015-2020)
  13.5.5 Grifols International SA Recent Development
13.6 Kedrion S.P.A.
  13.6.1 Kedrion S.P.A. Company Details
  13.6.2 Kedrion S.P.A. Business Overview and Its Total Revenue
  13.6.3 Kedrion S.P.A. Recombinant Coagulation Factors Introduction
  13.6.4 Kedrion S.P.A. Revenue in Recombinant Coagulation Factors Business (2015-2020)
  13.6.5 Kedrion S.P.A. Recent Development
13.7 Novo Nordisk A/S
  13.7.1 Novo Nordisk A/S Company Details
  13.7.2 Novo Nordisk A/S Business Overview and Its Total Revenue
  13.7.3 Novo Nordisk A/S Recombinant Coagulation Factors Introduction
  13.7.4 Novo Nordisk A/S Revenue in Recombinant Coagulation Factors Business (2015-2020)
  13.7.5 Novo Nordisk A/S Recent Development
13.8 Octapharma AG
  13.8.1 Octapharma AG Company Details
  13.8.2 Octapharma AG Business Overview and Its Total Revenue
  13.8.3 Octapharma AG Recombinant Coagulation Factors Introduction
  13.8.4 Octapharma AG Revenue in Recombinant Coagulation Factors Business (2015-2020)
  13.8.5 Octapharma AG Recent Development
13.9 Pfizer Inc.
  13.9.1 Pfizer Inc. Company Details
  13.9.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.9.3 Pfizer Inc. Recombinant Coagulation Factors Introduction
  13.9.4 Pfizer Inc. Revenue in Recombinant Coagulation Factors Business (2015-2020)
  13.9.5 Pfizer Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Recombinant Coagulation Factors Key Market Segments
Table 2. Key Players Covered: Ranking by Recombinant Coagulation Factors Revenue
Table 3. Ranking of Global Top Recombinant Coagulation Factors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Recombinant Coagulation Factors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Recombinant Factor VIII
Table 6. Key Players of Recombinant Factor IX
Table 7. Key Players of Von Willebrand Factor
Table 8. COVID-19 Impact Global Market: (Four Recombinant Coagulation Factors Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Recombinant Coagulation Factors Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Recombinant Coagulation Factors Players to Combat Covid-19 Impact
Table 13. Global Recombinant Coagulation Factors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Recombinant Coagulation Factors Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Recombinant Coagulation Factors Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Recombinant Coagulation Factors Market Share by Regions (2015-2020)
Table 17. Global Recombinant Coagulation Factors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Recombinant Coagulation Factors Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Recombinant Coagulation Factors Market Growth Strategy
Table 23. Main Points Interviewed from Key Recombinant Coagulation Factors Players
Table 24. Global Recombinant Coagulation Factors Revenue by Players (2015-2020) (Million US$)
Table 25. Global Recombinant Coagulation Factors Market Share by Players (2015-2020)
Table 26. Global Top Recombinant Coagulation Factors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Coagulation Factors as of 2019)
Table 27. Global Recombinant Coagulation Factors by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Recombinant Coagulation Factors Product Solution and Service
Table 30. Date of Enter into Recombinant Coagulation Factors Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 33. Global Recombinant Coagulation Factors Market Size Share by Type (2015-2020)
Table 34. Global Recombinant Coagulation Factors Revenue Market Share by Type (2021-2026)
Table 35. Global Recombinant Coagulation Factors Market Size Share by Application (2015-2020)
Table 36. Global Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 37. Global Recombinant Coagulation Factors Market Size Share by Application (2021-2026)
Table 38. North America Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 40. North America Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 41. North America Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 42. North America Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 43. North America Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 44. Europe Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 46. Europe Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 48. Europe Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 50. China Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 51. China Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 52. China Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 53. China Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 54. China Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 55. China Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 56. Japan Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 58. Japan Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 60. Japan Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 64. Southeast Asia Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 66. Southeast Asia Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 68. India Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 69. India Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 70. India Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 71. India Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 72. India Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 73. India Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Recombinant Coagulation Factors Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Recombinant Coagulation Factors Market Share (2019-2020)
Table 76. Central & South America Recombinant Coagulation Factors Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Recombinant Coagulation Factors Market Share by Type (2015-2020)
Table 78. Central & South America Recombinant Coagulation Factors Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Recombinant Coagulation Factors Market Share by Application (2015-2020)
Table 80. Baxter International Inc. Company Details
Table 81. Baxter International Inc. Business Overview
Table 82. Baxter International Inc. Product
Table 83. Baxter International Inc. Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 84. Baxter International Inc. Recent Development
Table 85. Bayer AG Company Details
Table 86. Bayer AG Business Overview
Table 87. Bayer AG Product
Table 88. Bayer AG Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 89. Bayer AG Recent Development
Table 90. Biogen Idec Company Details
Table 91. Biogen Idec Business Overview
Table 92. Biogen Idec Product
Table 93. Biogen Idec Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 94. Biogen Idec Recent Development
Table 95. CSL Ltd. Company Details
Table 96. CSL Ltd. Business Overview
Table 97. CSL Ltd. Product
Table 98. CSL Ltd. Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 99. CSL Ltd. Recent Development
Table 100. Grifols International SA Company Details
Table 101. Grifols International SA Business Overview
Table 102. Grifols International SA Product
Table 103. Grifols International SA Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 104. Grifols International SA Recent Development
Table 105. Kedrion S.P.A. Company Details
Table 106. Kedrion S.P.A. Business Overview
Table 107. Kedrion S.P.A. Product
Table 108. Kedrion S.P.A. Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 109. Kedrion S.P.A. Recent Development
Table 110. Novo Nordisk A/S Company Details
Table 111. Novo Nordisk A/S Business Overview
Table 112. Novo Nordisk A/S Product
Table 113. Novo Nordisk A/S Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 114. Novo Nordisk A/S Recent Development
Table 115. Octapharma AG Business Overview
Table 116. Octapharma AG Product
Table 117. Octapharma AG Company Details
Table 118. Octapharma AG Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 119. Octapharma AG Recent Development
Table 120. Pfizer Inc. Company Details
Table 121. Pfizer Inc. Business Overview
Table 122. Pfizer Inc. Product
Table 123. Pfizer Inc. Revenue in Recombinant Coagulation Factors Business (2015-2020) (Million US$)
Table 124. Pfizer Inc. Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Recombinant Coagulation Factors Market Share by Type: 2020 VS 2026
Figure 2. Recombinant Factor VIII Features
Figure 3. Recombinant Factor IX Features
Figure 4. Von Willebrand Factor Features
Figure 5. Global Recombinant Coagulation Factors Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Organizations Case Studies
Figure 9. Recombinant Coagulation Factors Report Years Considered
Figure 10. Global Recombinant Coagulation Factors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Recombinant Coagulation Factors Market Share by Regions: 2020 VS 2026
Figure 12. Global Recombinant Coagulation Factors Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Recombinant Coagulation Factors Market Share by Players in 2019
Figure 15. Global Top Recombinant Coagulation Factors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Coagulation Factors as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Coagulation Factors Revenue in 2019
Figure 17. North America Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Recombinant Coagulation Factors Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Baxter International Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Baxter International Inc. Revenue Growth Rate in Recombinant Coagulation Factors Business (2015-2020)
Figure 26. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bayer AG Revenue Growth Rate in Recombinant Coagulation Factors Business (2015-2020)
Figure 28. Biogen Idec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Biogen Idec Revenue Growth Rate in Recombinant Coagulation Factors Business (2015-2020)
Figure 30. CSL Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. CSL Ltd. Revenue Growth Rate in Recombinant Coagulation Factors Business (2015-2020)
Figure 32. Grifols International SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Grifols International SA Revenue Growth Rate in Recombinant Coagulation Factors Business (2015-2020)
Figure 34. Kedrion S.P.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Kedrion S.P.A. Revenue Growth Rate in Recombinant Coagulation Factors Business (2015-2020)
Figure 36. Novo Nordisk A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Novo Nordisk A/S Revenue Growth Rate in Recombinant Coagulation Factors Business (2015-2020)
Figure 38. Octapharma AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Octapharma AG Revenue Growth Rate in Recombinant Coagulation Factors Business (2015-2020)
Figure 40. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Pfizer Inc. Revenue Growth Rate in Recombinant Coagulation Factors Business (2015-2020)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed